|
Mood-Boosting
Fat: Good for Head and Heart?
by John Casey, Medical Writer
"The research work is a
long way from complete," says Dr. Joseph R. Hibbeln, chief of the outpatient
clinic at the National Institute on Alcohol Abuse and Alcoholism at the
National Institutes of Health, who has done extensive research on omega-3
and mood disorders. "And if someone is severely depressed or has acute psychiatric
problems, that person should not change treatment, but that being said,
what we are finding out about omega-3 and the treatment of mood disorders
is really astonishing."
|
|
"We know that patients with low concentrations of serotonin are associated with a greatly increased risk of depression and suicide," says Dr. Jerry Cott, a psychopharmacologist at the National Institutes of Health, who recently completed a review of omega-3 research on mood disorders. "Omega-3 appears to play an absolutely crucial role in maintaining serotonin levels and mood stabilization."
"Today, in our industrialized society, we get most of our fats from vegetable sources, such as corn and safflower," says Dr. Cott. "We eat oils rich in trans-fatty acids that are taken up more quickly than omega-3 and block omega-3 absorption. So not only do we eat less omega-3 in general, but the fats that we do eat tend to block it from getting to where we need it."
Although some biochemists have cast doubt on the efficacy of flax seed as a source of DHA-rich omega-3, studies show it has the same beneficial properties, without the fishy aftertaste of some fish-oil pills. "While flax seed is an omega-3, it has an 18-carbon chain, as opposed to the 20-carbon chain of DHA-containing omega-3 fish oils," says Dr. Hibbeln. "From a biochemistry standpoint, you'd think that flax seed would be an inefficient source of omega-3." But in studies with bipolar patients, Dr. Cott says, flax-seed oil appears to have an even faster effect than fish oil on mood stabilization. Some patients are reporting anxiety reduction within a half an hour of taking it," he says. "It's not supposed to be possible, but that's what we're seeing."
Although Dr. Stoll's omega-3 small study of 30 bipolar patients is the only such US study so far to have had its findings published in a peer-reviewed journal, several larger-scale studies are now underway here and in England to try to replicate Dr. Stoll's findings.
Here in the United States, Dr. Stoll and Dr. Lauren Marangell of Baylor University have two omega-3 studies in the works. "We got funding from that National Institutes of Health to do a larger follow-up study with 120 bipolar patients across a full year," says Dr. Stoll. "In the pilot study, we had only 30 patients, and they were all in different mood states and on varying medication or no medication. This study will be more controlled by having everyone in the same mood state and all on the same medications." Dr. Stoll also is conducting a study on omega-3 at Harvard University of 80 patients with regular, or unipolar, depression, who are not currently in treatment.
All of these findings are proving surprising, even to researchers in the field. "If these preliminary findings are replicated, then this is a remarkable discovery," says Dr. Cott. "We're seeing an efficacy with omega-3 that is equal to or better than current medications"
For more information
on the treatment of depression, bipolar disorder, and schizophrenia, visit
the National Institute of Mental Health at www.nimh.nih.gov
on the Web.
John Casey is a CBSHealthWatch staff member. He has written for Parade magazine and numerous online publications.
Reviewed for medical accuracy by a faculty physician, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School.
Copyright © 1999 Nutrisana International inc., all rights reserved